Search
Tag: medicines
Praxis Precision Medicines’ common counsel sells shares value $660,827 By Investing.com
In current transactions involving Praxis Precision Medicines, Inc. (NASDAQ:PRAX), Normal Counsel and Secretary Alex Nemiroff bought a good portion of…
Revolution Medicines experiences optimistic RMC-9805 examine outcomes By Investing.com
Revolution Medicines, Inc. has disclosed preliminary information from its first-in-human examine of RMC-9805, an investigational drug concentrating on strong tumors…
AstraZeneca to spice up income, launch new medicines by 2030
The Astrazeneca emblem is pictured on the World Synthetic Intelligence Convention 2021 in Shanghai, China, July 7, 2021.Costfoto | Future…
